STOCK TITAN

[Form 3] Acadia Healthcare Company, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Timothy Sides, Interim CFO of Acadia Healthcare (ACHC), reports direct beneficial ownership of 30,661 shares of common stock and ownership of stock options covering 4,825 underlying shares. The options include grants exercisable in 2022, 2023, and 2024 with exercise prices of $57.14, $53.40, and $80.87 and expirations in 2031, 2032, and 2033 respectively. Several equity awards have staggered vesting schedules that begin in 2026 and extend up to three years.

Timothy Sides, CFO ad interim di Acadia Healthcare (ACHC), dichiara la titolarità diretta di 30.661 azioni ordinarie e di opzioni su azioni che coprono 4.825 azioni sottostanti. Le opzioni comprendono assegnazioni esercitabili nel 2022, 2023 e 2024 con prezzi di esercizio di $57,14, $53,40 e $80,87 e scadenze rispettivamente nel 2031, 2032 e 2033. Diversi premi azionari hanno piani di vesting scaglionati che iniziano nel 2026 e si estendono fino a tre anni.

Timothy Sides, CFO interino de Acadia Healthcare (ACHC), informa de la propiedad directa de 30.661 acciones ordinarias y de opciones sobre acciones que cubren 4.825 acciones subyacentes. Las opciones incluyen concesiones ejercitables en 2022, 2023 y 2024 con precios de ejercicio de $57,14, $53,40 y $80,87 y vencimientos en 2031, 2032 y 2033, respectivamente. Varios premios de capital tienen calendarios de adquisición escalonados que comienzan en 2026 y se extienden hasta tres años.

Acadia Healthcare(ACHC)의 임시 최고재무책임자인 Timothy Sides는 30,661주 보통주의 직접 소유와 4,825주에 해당하는 스톡옵션을 보유하고 있음을 보고했습니다. 해당 옵션은 2022년, 2023년, 2024년에 행사 가능한 부여로, 행사가격은 각각 $57.14, $53.40, $80.87이며 만기는 각각 2031년, 2032년, 2033년입니다. 여러 주식 보상은 2026년에 시작하여 최대 3년 동안 단계적으로 권리 취득(베스팅)되는 일정이 적용됩니다.

Timothy Sides, directeur financier par intérim d'Acadia Healthcare (ACHC), déclare la propriété bénéficiaire directe de 30 661 actions ordinaires et la détention d'options sur actions portant sur 4 825 actions sous-jacentes. Les options incluent des attributions exerçables en 2022, 2023 et 2024 avec des prix d'exercice de $57,14, $53,40 et $80,87 et des échéances respectives en 2031, 2032 et 2033. Plusieurs récompenses en actions suivent des calendriers d'acquisition échelonnés débutant en 2026 et s'étalant sur jusqu'à trois ans.

Timothy Sides, geschäftsführender Finanzvorstand (Interim) von Acadia Healthcare (ACHC), meldet das unmittelbare wirtschaftliche Eigentum an 30.661 Stammaktien sowie Optionen auf 4.825 zugrundeliegende Aktien. Die Optionen umfassen Zuteilungen, die in den Jahren 2022, 2023 und 2024 ausübbar sind, mit Ausübungspreisen von $57,14, $53,40 und $80,87 und Fälligkeiten in den Jahren 2031, 2032 bzw. 2033. Mehrere Aktienzuwendungen haben gestaffelte Vesting-Pläne, die 2026 beginnen und sich über bis zu drei Jahre erstrecken.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine Form 3 showing an executive's direct share ownership and time‑based option grants, not a material change to capital structure.

The filing documents that the Interim CFO directly owns 30,661 common shares and holds options for 4,825 shares with specified exercise prices and long‑dated expirations. Vesting schedules are time‑based and spread across 2026–2028, indicating retention incentives rather than immediate dilution. This is a standard insider disclosure under Section 16.

TL;DR: Disclosure reflects executive compensation design with multi‑year vesting, aligning management with shareholder timelines.

The reported grants include multiple staggered vesting tranches (some vesting over two or three years), which suggests the company is using time‑based equity to retain executive leadership. All holdings are reported as direct, and no indirect holdings or related‑party arrangements are disclosed. The filing contains the required Power of Attorney remark for signature execution.

Timothy Sides, CFO ad interim di Acadia Healthcare (ACHC), dichiara la titolarità diretta di 30.661 azioni ordinarie e di opzioni su azioni che coprono 4.825 azioni sottostanti. Le opzioni comprendono assegnazioni esercitabili nel 2022, 2023 e 2024 con prezzi di esercizio di $57,14, $53,40 e $80,87 e scadenze rispettivamente nel 2031, 2032 e 2033. Diversi premi azionari hanno piani di vesting scaglionati che iniziano nel 2026 e si estendono fino a tre anni.

Timothy Sides, CFO interino de Acadia Healthcare (ACHC), informa de la propiedad directa de 30.661 acciones ordinarias y de opciones sobre acciones que cubren 4.825 acciones subyacentes. Las opciones incluyen concesiones ejercitables en 2022, 2023 y 2024 con precios de ejercicio de $57,14, $53,40 y $80,87 y vencimientos en 2031, 2032 y 2033, respectivamente. Varios premios de capital tienen calendarios de adquisición escalonados que comienzan en 2026 y se extienden hasta tres años.

Acadia Healthcare(ACHC)의 임시 최고재무책임자인 Timothy Sides는 30,661주 보통주의 직접 소유와 4,825주에 해당하는 스톡옵션을 보유하고 있음을 보고했습니다. 해당 옵션은 2022년, 2023년, 2024년에 행사 가능한 부여로, 행사가격은 각각 $57.14, $53.40, $80.87이며 만기는 각각 2031년, 2032년, 2033년입니다. 여러 주식 보상은 2026년에 시작하여 최대 3년 동안 단계적으로 권리 취득(베스팅)되는 일정이 적용됩니다.

Timothy Sides, directeur financier par intérim d'Acadia Healthcare (ACHC), déclare la propriété bénéficiaire directe de 30 661 actions ordinaires et la détention d'options sur actions portant sur 4 825 actions sous-jacentes. Les options incluent des attributions exerçables en 2022, 2023 et 2024 avec des prix d'exercice de $57,14, $53,40 et $80,87 et des échéances respectives en 2031, 2032 et 2033. Plusieurs récompenses en actions suivent des calendriers d'acquisition échelonnés débutant en 2026 et s'étalant sur jusqu'à trois ans.

Timothy Sides, geschäftsführender Finanzvorstand (Interim) von Acadia Healthcare (ACHC), meldet das unmittelbare wirtschaftliche Eigentum an 30.661 Stammaktien sowie Optionen auf 4.825 zugrundeliegende Aktien. Die Optionen umfassen Zuteilungen, die in den Jahren 2022, 2023 und 2024 ausübbar sind, mit Ausübungspreisen von $57,14, $53,40 und $80,87 und Fälligkeiten in den Jahren 2031, 2032 bzw. 2033. Mehrere Aktienzuwendungen haben gestaffelte Vesting-Pläne, die 2026 beginnen und sich über bis zu drei Jahre erstrecken.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Sides Timothy August

(Last) (First) (Middle)
ACADIA HEALTHCARE COMPANY, INC.
6100 TOWER CIRCLE, SUITE 1000

(Street)
FRANKLIN TN 37067

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/16/2025
3. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Interim CFO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 30,661(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option 03/31/2022 03/31/2031 Common Stock 775 $57.14 D
Stock Option 02/25/2023(2) 02/25/2032 Common Stock 1,550 $53.4 D
Stock Option 02/21/2024(3) 02/21/2033 Common Stock 2,500 $80.87 D
Explanation of Responses:
1. 625 shares will vest on February 25, 2026, 1,875 shares will vest on April 29, 2026, 1,000 shares will vest over a 2-year period in equal yearly installments beginning February 21, 2026, 5,000 shares will vest over a 2-year period in equal yearly installments beginning July 25, 2026, 2,998 shares will vest over a 2-year period in equal yearly installments beginning March 29, 2026, and 13,419 shares will vest over a 3-year period in equal yearly installments beginning March 10, 2026.
2. 775 of these stock options will vest on February 25, 2026.
3. 1,250 of these stock options will vest over a 2-year period in equal yearly installments beginning February 21, 2026.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Brian Farley as Attorney in Fact for Timothy Sides 08/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of ACHC does Timothy Sides directly own?

The filing shows 30,661 shares of Acadia Healthcare common stock held directly.

What stock options does Timothy Sides hold for ACHC?

He holds options exercisable into 775, 1,550, and 2,500 shares (total 4,825) with exercise prices of $57.14, $53.40, and $80.87.

When do the reported option grants expire?

The option expirations are shown as 03/31/2031, 02/25/2032, and 02/21/2033.

Are the reported equity awards subject to vesting?

Yes. Multiple tranches have time‑based vesting schedules beginning in 2026, including two‑ and three‑year installment vesting for several awards.

Does the Form 3 indicate indirect ownership or related‑party arrangements?

No. All reported holdings are listed as Direct (D) and no indirect beneficial ownership is disclosed.
Acadia Healthcar

NASDAQ:ACHC

ACHC Rankings

ACHC Latest News

ACHC Latest SEC Filings

ACHC Stock Data

2.07B
90.70M
1.74%
116.35%
11.66%
Medical Care Facilities
Services-specialty Outpatient Facilities, Nec
Link
United States
FRANKLIN